Table of Contents
INTRODUCTION
EXECUTIVE SUMMARY
MARKET ENVIRONMENT
General
Demographic Patterns
Macroeconomic Outlook
Healthcare Trends
National Health Expenditures
Pharmaceutical Supply & Demand
Pharmaceutical Shipments by Therapeutic Class
Patient Activity
Medical Conditions
Acute Conditions
Chronic Conditions
Animal Health Industry Outlook
Technological Overview of Biologics
Recombinant DNA Biologics
Biosimilars
Regulation
Regulation of Human Biologic Therapies
Regulation of Biosimilar Products
Regulation of Biologics Research & Testing Products
Regulation of Animal Biologics
PRODUCTS
General
Demand by Type
Monoclonal Antibodies
Cancer Treatment
Rheumatoid Arthritis
Macular Degeneration
Psoriasis
Infectious Disease
Other Applications
Vaccines & Toxoids
Vaccines for Human Health
Routine Immunizations
Influenza
Therapeutic Vaccines
Other Vaccines
Animal Vaccines
Hormones
Insulin
Human Growth Hormone
Teriparatide
Follicle-Stimulating Hormone
Estrogen
Calcitonin
Thyrotropin
Corticotropin
Other Hormones
Growth Factors
Erythropoietins
Colony-Stimulating Factors
Bone Morphogenetic Proteins
Other Growth Factors
Immunomodulators
Immunosuppressing Agents
Interferons
Other Immunomodulators
Blood & Blood Products
Plasma & Plasma Fractions
Whole Blood
Cellular Components
Enzymes
Enzyme Replacement Therapies
Neuromodulators
Digestive Enzymes
Thrombolytics
Diagnostics
Other Enzymes
Coagulation Factors
Antihemophilics
Other Coagulation Factors
Other Biologics
APPLICATIONS
General
Human Healthcare
Cancer
Autoimmune Diseases
Infectious Diseases
Blood Disorders
Diabetes
Other Conditions
Biologics for Other Uses
Animal Health
Research & All Other Applications
INDUSTRY STRUCTURE
General
Market Share
Competitive Strategies
Mergers & Acquisitions
Licensing & Related Agreements
Research & Development
Manufacturing
Marketing & Distribution
Company Profiles
Abbott Laboratories
Alere Incorporated
Alexion Pharmaceuticals Incorporated
Allergan Incorporated
Alnara Pharmaceuticals, see Eli Lilly
American Red Cross
Amgen Incorporated
Aptalis Pharma Incorporated
AstraZeneca plc
Axcan Intermediate Holdings, see Aptalis Pharma
Baxter International Incorporated
Bayer AG
BBI Enzymes, see Alere
Biogen Idec Incorporated
BioMarin Pharmaceutical Incorporated
BioVex Group, see Amgen
Blood Systems Incorporated
Bristol-Myers Squibb Company
Crucell, see Johnson & Johnson
CSL Limited
EKR Therapeutics Incorporated
Eli Lilly & Company
EMD Serono, see Merck KGaA
Emergent BioSolutions Incorporated
Enzon Pharmaceuticals, see sigma-tau Group
Eurand, see Aptalis Pharma
Facet Biotech, see Abbott Laboratories
Genentech, see Roche Holding
Genzyme, see Sanofi-Aventis
GlaxoSmithKline plc
GSK Biologicals, see GlaxoSmithKline
Halozyme Therapeutics Incorporated
Intercell AG
Inverness Medical Innovations, see Alere
Ipsen
Johnson & Johnson
Lonza Group Limited
Lundbeck (H.) A/S
Massachusetts Biologic Laboratories
Medarex, see Bristol-Myers Squibb
MedImmune, see AstraZeneca
Medtronic Incorporated
Mentor Worldwide, see Johnson & Johnson
Merck & Company Incorporated
Merck KGaA
Merial, see Sanofi-Aventis
New York Blood Center
Novartis AG
Novo Nordisk A/S
Organon Teknika, see Merck & Company
Ortho-McNeil-Janssen Pharmaceuticals, see Johnson & Johnson
Ovation Pharmaceuticals, see H. Lundbeck A/S
Percivia, see Johnson & Johnson
Pfizer Incorporated
Questcor Pharmaceuticals Incorporated
ratiopharm, see Teva Pharmaceutical Industries
Roche Holding Limited
Sandoz International, see Novartis
Sanofi-Aventis
Shire plc
sigma-tau Group
Solstice Neurosciences, see US WorldMeds
Solvay SA
Stryker Corporation
Teva Pharmaceutical Industries Limited
Theravance, see GlaxoSmithKline
TL Biopharmaceutical, see Lonza Group & Teva Pharmaceutical Industries
Trubion Pharmaceuticals, see Emergent BioSolutions
US WorldMeds LLC
Ventana Medical Systems, see Roche Holding
ViaCyte Incorporated
Vivante GMP Solutions, see Lonza Group
WiCell Research Institute
Wisconsin International Stem Cell Bank, see WiCell Research Institute
Wyeth, see Pfizer
ZyStor Therapeutics, see BioMarin Pharmaceutical
Other Companies Mentioned in Study
List of Tables
EXECUTIVE SUMMARY
Summary Table
MARKET ENVIRONMENT
Population & Households
Macroeconomic Indicators
National Health Expenditures by Type & Source of Payment
Pharmaceutical Supply & Demand
Pharmaceutical Shipments by Therapeutic Class
Patient Activity
Medical Conditions
Animal Population & Veterinary Health Expenditures
PRODUCTS
Biologics Demand by Type
Monoclonal Antibodies Demand
Vaccines Demand
Hormones Demand
Growth Factors Demand
Immunomodulators Demand
Blood & Blood Products Demand
Enzymes Demand
Coagulation Factors Demand
Other Biologics Demand
APPLICATIONS
Biologics Demand by Application
Biologics Demand for Human Healthcare by Condition & Use
Cancer Biologics Demand
Autoimmune Biologics Demand
Infectious Diseases Biologics Demand
Blood Disorders Biologics Demand
Diabetes Biologics Demand
Other Human Health Biologics Deman by Condition & Product
Biologics Demand for Other Applications
INDUSTRY STRUCTURE
US Biologics Sales by Company, 2010
Selected Acquisitions & Divestitures
Selected Cooperative Agreements
List of Charts
PRODUCTS
Biologics Demand by Product Type, 2010
APPLICATIONS
Human Healthcare Biologics Demand by Conditio & Use, 2010
INDUSTRY STRUCTURE
US Biologics Market Share, 2010
© by The Freedonia Group, Inc.